• Homepage
  • Viral Vector USP Training Program

Viral Vector Upstream Processing Course

Learn at Your Own Pace from Top Experts in the Industry

This course provides an overview of the essential elements necessary to be successful in the upstream processing of viral vectors (primarily AAV, LV and ADV): analytical tools, process development considerations and manufacturing strategies. It will also offer insight into the market and trends, as well as industry needs and challenges.

Key features:

  • Mix of self-paced and instructional units (4–5 hours per week, 35–40 hours total over 2.5 months)
  • Interactive collaborative platform
  • Limited synchronous activities
  • 98% recommendation rate

Apply Now


Who Should Attend

Lab managers, team leads, researchers, engineers and scientists with expertise in bioprocessing and basic knowledge of gene therapy. Fluent English is essential for optimal learning.


What You Will Learn

Upon completion of this course, you will:

  • Understand various viral vectors and cell line requirements
  • Explain upstream process development considerations and tools
  • Discuss process control and manufacturing strategies

How You Will Learn

This online course consists of self-led and instructional units presented via MS Teams. Each chapter includes live presentations, assignments, access to experts and Q&A sessions to encourage collaboration.

Focus Topics & Agenda

Structured for Your Success

Each of our courses is structured to maximize the success of our learners, with a mix of self-paced and instructional units taught by industry experts. Courses are organized into logical chapters that cover a complete topic in approximately 2.5 months.

Sept 20 - 21


Sept 22 - Oct 1

Introduction to Viral Vectors

Oct 4 - 15

Cell Lines, Viral Vectors and Banking

Oct 25 - Nov 10


Nov 22 - Dec 3

Process Development and Manufacturing

Dec 9 -  10


Learning Modules

Duration: 1.5 weeks

  • Viral vector market, trends and opportunities​
  • Description of the adeno-associated virus (AAV), lentivirus (LV) and adenovirus​ (ADV)
  • The basics of the viral vector manufacturing process

Duration: 2 weeks

  • Review of typical cell line used for viral vector production
  • Transient production (transfection, infection) and stable production
  • Introduction to cell banking, virus banking, required testing and regulatory considerations

Duration: 2.5 weeks

  • Where and why analytics are used in viral vector processes​
  • Introduction to the commonly used analytical solutions
  • Considerations and challenges when selecting analytical methods

Duration: 2 weeks

  • AAV, LV and ADV upstream workflows
  • Key process development considerations: cell culture optimization, adherent vs. suspension production, process optimization and scale-up
  • Production strategies for viral vectors
  • Process controls and analytics during production
How to Apply

Pricing and Special Rates

Registration fee: €2,500 + applicable taxes.

Special rates may be considered for public and academic institutes. Contact sartorius.academy@sartorius.com for further information.  

For terms and conditions, click here



The application period closes 31 August 2021. Successful applicants will be informed by 10 September 2021. 20 seats are reserved for participants from the biopharmaceutical industry.


How to Apply

Please complete the application below. A maximum of 30 participants (co-learners from both Sartorius and industry) will be accepted to the course. Questions about the application should be directed to sartorius.academy@sartorius.com.

Request Your Seat



Viral Vector Platforms

Learn more

Viral Vector Vaccines

Learn more


Learn more